KMID : 1100620170040030121
|
|
Clinical and Experimental Emergency Medicine 2017 Volume.4 No. 3 p.121 ~ p.127
|
|
Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury
|
|
Jones Alastair
Jarvis Paul
|
|
Abstract
|
|
|
Head injury is a common presenting complaint amongst emergency department patients. To date, there has been no widespread utilization of neuro-biomarkers to aid the diagnosis of traumatic brain injury. This review article explores which neuro-biomarkers could be used in the emergency department in aiding the clinical diagnosis of mild traumatic brain injury. Based on the available evidence, the most promising neuro-biomarkers appear to be Glial fibrillary acidic protein (GFAP) and Ubiquitin C-Terminal Hydrolase Isozyme L1 (UCH-L1) as these show significant rises in peripheral blood levels shortly after injury and these have been demonstrated to correlate with long-term clinical outcomes. Treatment strategies for minor traumatic brain injury in the emergency department setting are not well developed. The introduction of blood neuro-biomarkers could reduce unnecessary radiation exposure and provide an opportunity to improve the care of this patient group.
|
|
KEYWORD
|
|
Brain concussion, Biomarkers, Craniocerebral trauma
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|